Literature DB >> 19705298

Microvessel density and area in pituitary microadenomas.

Ewa Jasek1, Alicja Furgal-Borzych, Grzegorz J Lis, Jan A Litwin, Ewa Rzepecka-Wozniak, Franciszek Trela.   

Abstract

Microvessel density (MVD) and area (MVA) were assessed in 53 clinically silent pituitary microadenomas and in surrounding normal pituitary tissue using CD34 immunostaining and digital image analysis system. Twenty-one microadenomas (40%) were avascular; in the others, both MVD and MVA were significantly lower than in the normal pituitary tissue. No significant differences in MVD and MVA were found between hormonally immunonegative and immunopositive tumors or between different hormonal subtypes of immunopositive microadenomas. In microadenomas and in normal pituitary tissue, MVD and MVA were not significantly influenced by age or sex. These results suggest that pituitary adenomas at early developmental stage are either avascular or significantly less vascular than normal pituitary tissue and that differences in vascularity of pituitary adenomas associated with the variables of sex, age, clinical presentation and immunohistochemical phenotype reported in the literature can evolve with tumor growth and possibly acquire statistical significance in large macroadenomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19705298     DOI: 10.1007/s12022-009-9091-1

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  29 in total

1.  Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas.

Authors:  E Poblet; F Gonzalez-Palacios; F J Jimenez
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

Review 2.  New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.

Authors:  J Holash; S J Wiegand; G D Yancopoulos
Journal:  Oncogene       Date:  1999-09-20       Impact factor: 9.867

3.  Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.

Authors:  N Garcia de la Torre; I Buley; J A H Wass; H E Turner
Journal:  Endocr Relat Cancer       Date:  2006-09       Impact factor: 5.678

4.  Angiogenesis in pituitary adenomas and the normal pituitary gland.

Authors:  H E Turner; Z Nagy; K C Gatter; M M Esiri; A L Harris; J A Wass
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

5.  Microvessel density in human normal and neoplastic parathyroids.

Authors:  Paolo Viacava; Guido Bocci; Giovanni Fanelli; Filomena Cetani; Claudio Marcocci; Generoso Bevilacqua; Antonio Giuseppe Naccarato
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 6.  Evaluation of microvascular density in tumors: pro and contra.

Authors:  Beatrice Nico; Vincenzo Benagiano; Domenica Mangieri; Nicola Maruotti; Angelo Vacca; Domenico Ribatti
Journal:  Histol Histopathol       Date:  2008-05       Impact factor: 2.303

7.  Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.

Authors:  N Garcia de la Torre; I Buley; J A H Wass; D G Jackson; H E Turner
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

8.  Immunocytochemical Investigations on the Vascularization of Pituitary Adenomas.

Authors:  Marek Pawlikowski; Hanna Pisarek; Maria Jaranowska
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

Review 9.  Physiological and pathological angiogenesis in the endocrine system.

Authors:  Miklós I Góth; Erika Hubina; Stefanos Raptis; György M Nagy; Béla E Tóth
Journal:  Microsc Res Tech       Date:  2003-01-01       Impact factor: 2.769

10.  Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression.

Authors:  A Couvelard; D O'Toole; H Turley; R Leek; A Sauvanet; C Degott; P Ruszniewski; J Belghiti; A L Harris; K Gatter; F Pezzella
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

View more
  8 in total

1.  Endocan, a new invasion and angiogenesis marker of pituitary adenomas.

Authors:  Fumihiro Matano; Daizo Yoshida; Yudo Ishii; Shigeyuki Tahara; Akira Teramoto; Akio Morita
Journal:  J Neurooncol       Date:  2014-02-07       Impact factor: 4.130

2.  Expression of RECK in endothelial cells of glioma: comparison with CD34 and VEGF expressions.

Authors:  Nunung Nur Rahmah; Keiichi Sakai; Kenji Sano; Kazuhiro Hongo
Journal:  J Neurooncol       Date:  2011-12-20       Impact factor: 4.130

3.  Remote limb ischemic postconditioning promotes motor function recovery in a rat model of ischemic stroke via the up-regulation of endogenous tissue kallikrein.

Authors:  Dan Liang; Xi-Biao He; Zheng Wang; Ce Li; Bei-Yao Gao; Jun-Fa Wu; Yu-Long Bai
Journal:  CNS Neurosci Ther       Date:  2018-02-04       Impact factor: 5.243

4.  Enhanced nestin expression and small blood vessels in human pituitary adenomas.

Authors:  María Inés Perez-Millan; Silvia Inés Berner; Guillermina María Luque; Cristian De Bonis; Gustavo Sevlever; Damasia Becu-Villalobos; Carolina Cristina
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

5.  Assessment of microvessel perfusion of pituitary adenomas: a feasibility study using turbo spin-echo-based intravoxel incoherent motion imaging.

Authors:  Kiyohisa Kamimura; Masanori Nakajo; Tomohide Yoneyama; Yoshihiko Fukukura; Shingo Fujio; Yuko Goto; Takashi Iwanaga; Yuta Akamine; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2019-12-10       Impact factor: 5.315

6.  Correlations of vascular architecture and angiogenesis with pituitary adenoma histotype.

Authors:  Shingo Takano; Hiroyoshi Akutsu; Takuma Hara; Tetsuya Yamamoto; Akira Matsumura
Journal:  Int J Endocrinol       Date:  2014-11-09       Impact factor: 3.257

Review 7.  Angiogenesis in pituitary adenomas: human studies and new mutant mouse models.

Authors:  Carolina Cristina; Guillermina María Luque; Gianina Demarchi; Felicitas Lopez Vicchi; Lautaro Zubeldia-Brenner; Maria Ines Perez Millan; Sofia Perrone; Ana Maria Ornstein; Isabel M Lacau-Mengido; Silvia Inés Berner; Damasia Becu-Villalobos
Journal:  Int J Endocrinol       Date:  2014-11-18       Impact factor: 3.257

8.  MiR-665 aggravates heart failure via suppressing CD34-mediated coronary microvessel angiogenesis.

Authors:  Jiahui Fan; Huaping Li; Xiang Nie; Zhongwei Yin; Yanru Zhao; Xudong Zhang; Shuai Yuan; Yuying Li; Chen Chen; Dao Wen Wang
Journal:  Aging (Albany NY)       Date:  2018-09-21       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.